Riskpilot← Back to searchSign inGet full accessCLINICAL RESEARCH ApS
APSActiveCVR 31081653Møllemarksvej 11Other human health activities n.e.c. · NACE 8699Est. 20074 employees
Revenue 2025
DKK 802K
-10% vs 2024
EBITDA margin
-0.6%
+90% vs 2024
Equity ratio
21.5%
Financial strength
Net profit 2025
DKK -14K
+66% vs 2024
| Revenue | DKK 802K | -10% |
| EBITDA | DKK -5K | +90% |
| Net profit | DKK -14K | +66% |
| Total assets | DKK 351K | +31% |
| Equity | DKK 76K | -16% |
| Employees | 4 | — |
Legal name
CLINICAL RESEARCH ApS
CVR number
31081653
Legal form
Anpartsselskab
NACE code
8699 · Other human health activities n.e.c.
Founded
5. december 2007
Share capital
DKK 125.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at udføre monitorering af kliniske forsøg
Address
Møllemarksvej 11
Phone
+4566166090
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 839 | 833 | 913 | 793 | 701 | 632 | 475 | 325 | 972 | 1.104 | 1.525 | 1.044 | 887 | 802 |
| Staff expenses | -592 | -618 | -658 | -605 | -590 | -641 | -603 | -149 | -697 | -784 | -934 | -914 | -939 | -807 |
| EBITDA | 247 | 214 | 255 | 188 | 111 | -8 | -128 | 176 | 275 | 321 | 592 | 130 | -52 | -5 |
| Depreciation & amort. | -0 | -0 | -0 | -20 | -30 | -30 | -30 | -50 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 247 | 214 | 255 | 168 | 81 | -38 | -158 | 126 | 275 | 321 | 592 | 130 | -52 | -5 |
| Net financials | -1 | 1 | 0 | 0 | -0 | 0 | -1 | -0 | -1 | -3 | -3 | 0 | 0 | 0 |
| Profit before tax | 247 | 215 | 255 | 168 | 81 | -38 | -156 | 142 | 274 | 318 | 589 | 130 | -51 | -5 |
| Tax | 65 | 55 | 64 | 41 | 19 | 0 | 2 | 8 | 51 | 70 | 131 | 30 | -9 | 9 |
| Net profit | 182 | 160 | 191 | 127 | 62 | -39 | -157 | 133 | 223 | 247 | 458 | 101 | -42 | -14 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 440 | 398 | 413 | 599 | 456 | 352 | 214 | 79 | 675 | 554 | 847 | 470 | 269 | 351 |
| Equity | 126 | 126 | 127 | 129 | 190 | 87 | -71 | 63 | 286 | 373 | 592 | 232 | 90 | 76 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 315 | 272 | 287 | 463 | 256 | 255 | 277 | 16 | 389 | 180 | 255 | 238 | 179 | 275 |
| Total debt | 315 | 272 | 287 | 463 | 256 | 255 | 277 | 16 | 389 | 180 | 255 | 238 | 179 | 275 |
EBITDA margin
-0.6%
This company
15.8%
Market median
-104% vs market
20122025
Equity ratio
21.5%
This company
38.2%
Market median
-44% vs market
20122025
Return on equity
-19.1%
This company
18.4%
Market median
-204% vs market
20122025
Net profit margin
-1.8%
This company
8.1%
Market median
-122% vs market
20122025
Asset turnover
2.28×
This company
1.12×
Market median
+104% vs market
20122025
Debt / equity
3.65×
This company
0.62×
Market median
-489% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AB Management | Management | 2007 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ANETTE BONDE DALGAARD HOLDING ApS | Company | 100.0% | 100.0% | 2007 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ANETTE BONDE DALGAARD HOLDING ApS
CLINICAL RESEARCH ApS Board members of CLINICAL RESEARCH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anette Bonde Dalgaard | Management | 0 companies |